Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Ramsbottom KM"'
Autor:
Van Der Byl W; The Kirby Institute for Infection and Immunity, UNSW, Sydney, NSW, Australia; School of Medical Sciences, Faculty of Medicine, UNSW, Sydney, NSW, Australia., Nüssing S; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia., Peters TJ; Garvan Institute of Medical Research, Sydney, NSW, Australia; University of New South Wales Sydney, Sydney, NSW, Australia., Ahn A; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia., Li H; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel., Ledergor G; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel., David E; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel., Koh AS; Department of Pathology, University of Chicago, Chicago, IL, USA., Wagle MV; Garvan Institute of Medical Research, Sydney, NSW, Australia; John Curtin School of Medical Research, ANU, Canberra, ACT, Australia., Deguit CDT; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., de Menezes MN; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia., Travers A; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Sampurno S; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Ramsbottom KM; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Li R; Center for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, CA, USA., Kallies A; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia; Department of Microbiology and Immunology, The University of Melbourne, Melbourne, VIC, Australia., Beavis PA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia., Jungmann R; Faculty of Physics and Center for Nanoscience, Ludwig Maximilian University, Munich, Germany; Max Planck Institute of Biochemistry, Martinsried, Germany., Bastings MMC; Institute of Materials, School of Engineering, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland; Interfaculty Bioengineering Institute, School of Engineering, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland., Belz GT; The Frazer Institute, The University of Queensland, Brisbane, QLD, Australia; Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia., Goel S; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia., Trapani JA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia., Crabtree GR; Center for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, CA, USA; Departments of Pathology and Developmental Biology, Stanford University School of Medicine, Stanford, CA, USA., Chang HY; Center for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, CA, USA., Amit I; Department of Immunology, Weizmann Institute of Science, Rehovot, Israel., Goodnow CC; School of Medical Sciences, Faculty of Medicine, UNSW, Sydney, NSW, Australia; Garvan Institute of Medical Research, Sydney, NSW, Australia., Luciani F; The Kirby Institute for Infection and Immunity, UNSW, Sydney, NSW, Australia; School of Medical Sciences, Faculty of Medicine, UNSW, Sydney, NSW, Australia. Electronic address: luciani@unsw.edu.au., Parish IA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia; John Curtin School of Medical Research, ANU, Canberra, ACT, Australia. Electronic address: ian.parish@petermac.org.
Publikováno v:
Immunity [Immunity] 2024 Jun 11; Vol. 57 (6), pp. 1324-1344.e8. Date of Electronic Publication: 2024 May 21.
Autor:
Lelliott EJ; Centre for Cancer Immunotherapy, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Density and Health Sciences, The University of Melbourne, Parkville, VIC, Australia., Ramsbottom KM; Centre for Cancer Immunotherapy, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Dowling MR; Centre for Cancer Immunotherapy, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Density and Health Sciences, The University of Melbourne, Parkville, VIC, Australia., Shembrey C; Centre for Cancer Immunotherapy, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Density and Health Sciences, The University of Melbourne, Parkville, VIC, Australia., Noori T; Centre for Cancer Immunotherapy, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Kearney CJ; Centre for Cancer Immunotherapy, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Density and Health Sciences, The University of Melbourne, Parkville, VIC, Australia., Michie J; Centre for Cancer Immunotherapy, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Parish IA; Centre for Cancer Immunotherapy, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Density and Health Sciences, The University of Melbourne, Parkville, VIC, Australia., Jordan MA; College of Public Health, Medical & Veterinary Sciences, James Cook University, Townsville, QLD, Australia., Baxter AG; College of Public Health, Medical & Veterinary Sciences, James Cook University, Townsville, QLD, Australia.; Central Clinical School, Monash University, Prahran, VIC, Australia., Young ND; Department of Veterinary Biosciences, Melbourne Veterinary School, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, VIC, Australia., Brennan AJ; Centre for Cancer Immunotherapy, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Density and Health Sciences, The University of Melbourne, Parkville, VIC, Australia., Oliaro J; Centre for Cancer Immunotherapy, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Density and Health Sciences, The University of Melbourne, Parkville, VIC, Australia.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Jul 06; Vol. 13, pp. 931630. Date of Electronic Publication: 2022 Jul 06 (Print Publication: 2022).
Autor:
Wellinger LC; Roche Pharma Research and Early Development, Oncology Discovery, Roche Innovation Center Basel, Basel, Switzerland., Hogg SJ; Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Newman DM; Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia., Friess T; Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany., Geiss D; Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany., Michie J; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia., Ramsbottom KM; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia., Bacac M; Roche Pharma Research and Early Development, Oncology Discovery, Roche Innovation Center Zurich, Schlieren, Switzerland., Fauti T; Roche Pharma Research and Early Development, Oncology Discovery, Roche Innovation Center Zurich, Schlieren, Switzerland., Marbach D; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland., Jarassier L; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland., Thienger P; Department for BioMedical Research, University of Bern, Bern, Switzerland., Paehler A; Roche Pharma Research and Early Development, Oncology Discovery, Roche Innovation Center Basel, Basel, Switzerland., Cluse LA; Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia., Kearney CJ; Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Vervoort SJ; Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia., Trapani JA; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia., Oliaro J; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia., Shortt J; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.; Monash Haematology, Monash Health, Clayton, Australia.; School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia., Ruefli-Brasse A; Pfizer, South San Francisco, California., Rohle D; Roche Pharma Research and Early Development, Oncology Discovery, Roche Innovation Center Basel, Basel, Switzerland. drohle@ridgelinediscovery.com ricky.johnstone@petermac.org., Johnstone RW; Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia. drohle@ridgelinediscovery.com ricky.johnstone@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2022 Jan; Vol. 10 (1), pp. 87-107. Date of Electronic Publication: 2021 Nov 15.
Autor:
Freeman AJ; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Vic., Australia., Vervoort SJ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Vic., Australia.; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia., Michie J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Vic., Australia., Ramsbottom KM; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia., Silke J; Inflammation Department, Walter and Eliza Hall Institute of Medical Research, Parkville, Vic., Australia.; Department of Medical Biology, The University of Melbourne, Melbourne, Vic., Australia., Kearney CJ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Vic., Australia.; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Vic., Australia., Oliaro J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Vic., Australia.; Department of Immunology and Pathology, Monash University, Melbourne, Vic., Australia.
Publikováno v:
EMBO reports [EMBO Rep] 2021 Nov 04; Vol. 22 (11), pp. e53391. Date of Electronic Publication: 2021 Sep 01.
Autor:
Lelliott EJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Kong IY; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia., Zethoven M; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Ramsbottom KM; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Martelotto LG; Single Cell Innovation Laboratory, The University of Melbourne, Parkville, Victoria, Australia., Meyran D; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Université de Paris, INSERM, U976 HIPI Unit, Institut de Recherche Saint-Louis, Paris, France., Zhu JJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Costacurta M; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Kirby L; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Sandow JJ; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., Lim L; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Dominguez PM; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Todorovski I; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Haynes NM; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.; Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia., Beavis PA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Neeson PJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Hawkins ED; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia., McArthur GA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Parish IA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Johnstone RW; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Oliaro J; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.; Department of Immunology, Central Clinical School, Monash University, Melbourne, Victoria, Australia., Sheppard KE; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. conor.kearney@petermac.org karen.sheppard@petermac.org stephin.vervoort@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.; Department of Biochemistry and Pharmacology, The University of Melbourne, Parkville, Victoria, Australia., Kearney CJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. conor.kearney@petermac.org karen.sheppard@petermac.org stephin.vervoort@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia., Vervoort SJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. conor.kearney@petermac.org karen.sheppard@petermac.org stephin.vervoort@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
Publikováno v:
Cancer discovery [Cancer Discov] 2021 Oct; Vol. 11 (10), pp. 2582-2601. Date of Electronic Publication: 2021 May 14.
Autor:
Wagle MV; John Curtin School of Medical Research, Australian National University, ACT, Australia., Vervoort SJ; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Kelly MJ; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Van Der Byl W; The Kirby Institute for Infection and Immunity, UNSW, Sydney, NSW, Australia.; Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia., Peters TJ; Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; University of New South Wales, Sydney, NSW, Australia., Martin BP; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Martelotto LG; Centre for Cancer Research, VCCC, University of Melbourne, Melbourne, VIC, Australia., Nüssing S; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Ramsbottom KM; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Torpy JR; Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; University of New South Wales, Sydney, NSW, Australia., Knight D; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Reading S; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Thia K; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Miosge LA; John Curtin School of Medical Research, Australian National University, ACT, Australia., Howard DR; John Curtin School of Medical Research, Australian National University, ACT, Australia., Gloury R; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.; Department of Microbiology and Immunology, The University of Melbourne, Melbourne, VIC, Australia.; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia., Gabriel SS; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.; Department of Microbiology and Immunology, The University of Melbourne, Melbourne, VIC, Australia.; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia., Utzschneider DT; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.; Department of Microbiology and Immunology, The University of Melbourne, Melbourne, VIC, Australia., Oliaro J; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Department of Immunology, Central Clinical School, Monash University, Melbourne, VIC, Australia., Powell JD; Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University of Medicine, Baltimore, MD, USA., Luciani F; The Kirby Institute for Infection and Immunity, UNSW, Sydney, NSW, Australia.; Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia., Trapani JA; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Johnstone RW; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Kallies A; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.; Department of Microbiology and Immunology, The University of Melbourne, Melbourne, VIC, Australia., Goodnow CC; John Curtin School of Medical Research, Australian National University, ACT, Australia. c.goodnow@garvan.org.au.; Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia. c.goodnow@garvan.org.au.; Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. c.goodnow@garvan.org.au., Parish IA; John Curtin School of Medical Research, Australian National University, ACT, Australia. ian.parish@petermac.org.; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. ian.parish@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia. ian.parish@petermac.org.
Publikováno v:
Nature communications [Nat Commun] 2021 May 13; Vol. 12 (1), pp. 2782. Date of Electronic Publication: 2021 May 13.
Autor:
Kearney CJ; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia. ricky.johnstone@petermac.org conor.kearney@petermac.org jane.oliaro@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3010, Australia., Vervoort SJ; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3010, Australia., Ramsbottom KM; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia., Todorovski I; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia., Lelliott EJ; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia., Zethoven M; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia., Pijpers L; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia., Martin BP; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia., Semple T; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia., Martelotto L; Centre for Cancer Research, University of Melbourne, Melbourne 3000, VIC, Australia., Trapani JA; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3010, Australia.; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia., Parish IA; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3010, Australia.; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia., Scott NE; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne 3000, Australia., Oliaro J; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3010, Australia. ricky.johnstone@petermac.org conor.kearney@petermac.org jane.oliaro@petermac.org.; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia., Johnstone RW; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia. ricky.johnstone@petermac.org conor.kearney@petermac.org jane.oliaro@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3010, Australia.; Cancer Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.
Publikováno v:
Science advances [Sci Adv] 2021 Feb 19; Vol. 7 (8). Date of Electronic Publication: 2021 Feb 19 (Print Publication: 2021).
Autor:
Lelliott EJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Mangiola S; The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia., Ramsbottom KM; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Zethoven M; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Lim L; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Lau PKH; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Oliver AJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Martelotto LG; Single Cell Innovation Laboratory, The University of Melbourne, Parkville, Victoria, Australia., Kirby L; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Martin C; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Patel RP; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Slater A; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Cullinane C; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Papenfuss AT; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Haynes NM; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., McArthur GA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia., Oliaro J; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Department of Immunology, Central Clinical School, Monash University, Melbourne, Victoria, Australia., Sheppard KE; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. karen.sheppard@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.; Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australia.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2021 Feb; Vol. 9 (2), pp. 136-146. Date of Electronic Publication: 2020 Dec 10.
Autor:
Freeman AJ; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, VIC 3010, Australia., Vervoort SJ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, VIC 3010, Australia; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Ramsbottom KM; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Kelly MJ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, VIC 3010, Australia; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Michie J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, VIC 3010, Australia., Pijpers L; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Johnstone RW; Sir Peter MacCallum Department of Oncology, The University of Melbourne, VIC 3010, Australia; Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Kearney CJ; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, VIC 3010, Australia. Electronic address: conor.kearney@petermac.org., Oliaro J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, VIC 3010, Australia; Department of Immunology, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia. Electronic address: jane.oliaro@petermac.org.
Publikováno v:
Cell reports [Cell Rep] 2019 Sep 10; Vol. 28 (11), pp. 2784-2794.e5.
Autor:
Lelliott EJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Cullinane C; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Martin CA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Walker R; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Ramsbottom KM; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Souza-Fonseca-Guimaraes F; Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia.; Division of Molecular Immunology, The Walter Eliza Hall Institute of Medical Research, Parkville, VIC, Australia., Abuhammad S; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Michie J; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Kirby L; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Young RJ; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Slater A; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Lau P; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Meeth K; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA., Oliaro J; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Haynes N; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Department of Pathology, University of Melbourne, Melbourne, VIC, Australia., McArthur GA; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Department of Medicine, St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia., Sheppard KE; Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. karen.sheppard@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia. karen.sheppard@petermac.org.; Department of Biochemistry and Molecular Biology, University of Melbourne, Melbourne, VIC, Australia. karen.sheppard@petermac.org.
Publikováno v:
Scientific reports [Sci Rep] 2019 Feb 04; Vol. 9 (1), pp. 1225. Date of Electronic Publication: 2019 Feb 04.